We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Ichor Holdings
ICHR
$2.56B
| $3.16M | ﹤0.01% |
130,526
+29,184
| +29% | +$863K |
|
2127
Oscar Health
OSCR
$8.61B
| $3.16M | ﹤0.01% |
633,367
+211,859
| +50% | +$1.24M |
|
|
SWTX
2128
DELISTED
SpringWorks Therapeutics
SWTX
| $3.16M | ﹤0.01% |
110,716
-1,208
| -1% | -$34.6K |
|
|
GOGL
2129
DELISTED
Golden Ocean Group
GOGL
| $3.15M | ﹤0.01% |
427,217
-12,319
| -3% | -$123K |
|
|
MMP
2130
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $3.15M | ﹤0.01% |
66,255
-33,495
| -34% | -$1.68M |
|
|
IMGN
2131
DELISTED
Immunogen Inc
IMGN
| $3.13M | ﹤0.01% |
654,039
-304,512
| -32% | -$1.61M |
|
|
OPTU
2132
Optimum Communications Inc
OPTU
$301M
| $3.12M | ﹤0.01% |
534,396
-15,848
| -3% | -$152K |
|
2133
The GEO Group
GEO
$4.04B
| $3.1M | ﹤0.01% |
402,573
-7,151
| -2% | -$52.8K |
|
2134
Ooma
OOMA
$604M
| $3.1M | ﹤0.01% |
251,831
-16,531
| -6% | -$205K |
|
2135
TG Therapeutics
TGTX
$7.62B
| $3.09M | ﹤0.01% |
522,029
+144,022
| +38% | +$945K |
|
2136
Bally's
BALY
$658M
| $3.08M | ﹤0.01% |
156,106
-7,523
| -5% | -$172K |
|
2137
Matthews International
MATW
$739M
| $3.08M | ﹤0.01% |
137,547
-5,392
| -4% | -$140K |
|
2138
Compañía de Minas Buenaventura
BVN
$8.67B
| $3.08M | ﹤0.01% |
457,344
+4,400
| +1% | +$26.1K |
|
2139
Target Hospitality
TH
$1.64B
| $3.06M | ﹤0.01% |
242,902
-44,585
| -16% | -$558K |
|
2140
Novavax
NVAX
$1.31B
| $3.06M | ﹤0.01% |
168,171
-6,426
| -4% | -$278K |
|
|
OLPX
2141
DELISTED
Olaplex Holdings
OLPX
| $3.05M | ﹤0.01% |
319,769
+26,578
| +9% | +$381K |
|
|
BCOV
2142
DELISTED
Brightcove, Inc.
BCOV
| $3.05M | ﹤0.01% |
484,389
-5,268
| -1% | -$34.1K |
|
|
ONL
2143
Orion Office REIT
ONL
$160M
| $3.05M | ﹤0.01% |
348,696
-3,539
| -1% | -$36.3K |
|
2144
Kymera Therapeutics
KYMR
$8.94B
| $3.04M | ﹤0.01% |
139,635
+12,851
| +10% | +$339K |
|
2145
German American Bancorp
GABC
$1.9B
| $3.03M | ﹤0.01% |
84,766
-1,729
| -2% | -$63.8K |
|
2146
Clover Health Investments
CLOV
$2.51B
| $3.03M | ﹤0.01% |
1,780,071
+474,829
| +36% | +$1.24M |
|
|
ILPT
2147
Industrial Logistics Properties Trust
ILPT
$586M
| $3.01M | ﹤0.01% |
546,881
-257,973
| -32% | -$2.33M |
|
2148
Nuveen Short-Term REIT ETF
NURE
$35.5M
| $2.99M | ﹤0.01% |
100,723
-760
| -0.7% | -$25.5K |
|
2149
Brookdale Senior Living
BKD
$3.4B
| $2.99M | ﹤0.01% |
699,881
-652,587
| -48% | -$3.09M |
|
2150
Petco
WOOF
$794M
| $2.99M | ﹤0.01% |
267,580
-562,066
| -68% | -$8.21M |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.